| Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC (NCT06436144) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2024-06-01 |
| Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy (NCT06470880) | The Christie NHS Foundation Trust | 2024-06-01 |
| Effect of Vitamin C on Postoperative Pulmonary Complications After Intracranial Tumor Surgery (NCT06421688) | Qianfoshan Hospital | 2024-06-01 |
| Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis (NCT05907330) | Curacle Co., Ltd. | 2024-06-01 |
| Evaluation of Hydroxychloroquine to Prevent CIPN (NCT05689359) | University of Arizona | 2024-06-01 |
| T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer (NCT06045767) | Ari Raphael | 2024-06-01 |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 (NCT06312761) | University of Washington | 2024-06-01 |
| Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma (NCT05973903) | Tel Aviv Medical Center | 2024-06-01 |
| CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer (NCT06881537) | Shanghai Changzheng Hospital | 2024-06-01 |
| A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases (NCT06218888) | Fujian Cancer Hospital | 2024-06-01 |
| Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (NCT06413342) | Zhejiang Cancer Hospital | 2024-06-01 |
| Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies (NCT06462248) | Chi Kong Li | 2024-06-01 |
| Oral Iloprost for the Prevention of Lung Cancer In Former Smokers (NCT05411107) | National Cancer Institute (NCI) | 2024-06-01 |
| Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model (NCT06420440) | Chen Xiaoping | 2024-06-01 |
| Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer (NCT06474806) | Curasight | 2024-06-01 |
| A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain (NCT06814535) | Cairo University | 2024-06-01 |
| Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA). (NCT06227897) | Sun Yat-sen University | 2024-06-01 |
| Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension (NCT06683040) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2024-06-01 |
| Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis (NCT06302049) | Sadat City University | 2024-06-01 |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers (NCT05153304) | University of California, San Diego | 2024-06-01 |
| Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI). (NCT06253923) | SHINKEI Therapeutics, Inc | 2024-06-01 |
| Diabetes Islet Preservation Immune Treatment (NCT02586831) | Camillo Ricordi and Jay Skyler | 2024-06-01 |
| Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore (NCT06157996) | Nanfang Hospital, Southern Medical University | 2024-06-01 |
| Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia (NCT06128356) | NYU Langone Health | 2024-06-01 |
| Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation (NCT06414915) | National Cancer Center, China | 2024-06-01 |
| Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years (NCT04026984) | RedHill Biopharma Limited | 2024-06-01 |
| A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC (NCT06434740) | Sir Run Run Shaw Hospital | 2024-06-01 |
| FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC (NCT06403111) | Changzhou No.2 People's Hospital | 2024-06-01 |
| Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. (NCT06452433) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-06-01 |
| Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab (NCT06415851) | Zhangfa Song | 2024-06-01 |
| Radiotherapy to All Residual Lesions After Chemoimmunotherapy (NCT06479473) | Anhui Provincial Hospital | 2024-06-01 |
| A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment (NCT06412068) | Sun Yat-sen University | 2024-06-01 |
| Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment (NCT06279195) | Endeavor Health | 2024-06-01 |
| Opioid Free Versus Opioid Balanced Anesthesia in Ophthalmic Surgery (NCT06382831) | Indonesia University | 2024-06-01 |
| Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer (NCT06463171) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-06-01 |
| Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy (NCT06419140) | Zhejiang Cancer Hospital | 2024-06-01 |
| A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B (NCT06452693) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-06-01 |
| Platelet Rich Plasma Injections In Young And Old Human Subjects (NCT06451120) | University of California, San Francisco | 2024-06-01 |
| Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia (NCT05319249) | German Cancer Research Center | 2024-06-01 |
| Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children (NCT06467994) | Chinese University of Hong Kong | 2024-06-01 |
| Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment (NCT06304025) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2024-06-01 |
| Combination of Toripalimab and JS004 Therapy for ccRCC (NCT06690697) | Fudan University | 2024-06-01 |
| Solriamfetol for the Treatment of Multiple Sclerosis Fatigue (NCT06170970) | Johns Hopkins University | 2024-06-01 |
| Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism (NCT06478875) | Assistance Publique - Hôpitaux de Paris | 2024-06-01 |
| PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) (NCT06542393) | Federal University of São Paulo | 2024-06-01 |
| A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers (NCT05509153) | Western Sydney Local Health District | 2024-06-01 |
| Fecal Microbiota Transplantation in Axial Spondyloarthritis (NCT06451588) | University Hospital of North Norway | 2024-06-01 |
| REMAP ECMO - Beta Receptor Modulation Trial (NCT06522594) | Erasmus Medical Center | 2024-06-01 |
| D-chiro-inositol and AUB (NCT06398145) | University Of Perugia | 2024-06-01 |
| Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer (NCT06361030) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-06-01 |
| The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension (NCT06473493) | Shanghai Changzheng Hospital | 2024-06-01 |
| MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction (NCT06191965) | Mclean Hospital | 2024-06-01 |
| Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer (NCT06454435) | Tianjin Medical University Cancer Institute and Hospital | 2024-06-01 |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT06343311) | Estrella Biopharma, Inc. | 2024-06-01 |
| Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients (NCT04729582) | Simone Spuler, MD | 2024-06-01 |
| Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer (NCT06446206) | The First Hospital of Jilin University | 2024-06-01 |
| Lavender Aromatherapy to Decrease Anxiety/Pain Perception During Office Hysteroscopy (NCT06316934) | University of Florida | 2024-06-01 |
| A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP (NCT06658834) | Institute of Hematology & Blood Diseases Hospital, China | 2024-06-01 |
| FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer (NCT06405113) | Changzhou No.2 People's Hospital | 2024-06-01 |
| Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation. (NCT06197763) | St. Boniface Hospital | 2024-06-01 |
| Fortified Oral Rehydration Therapy for Pediatric Diarrhea (NCT06137014) | Paul A Breslin | 2024-06-01 |
| Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer (NCT06443671) | Peking University Cancer Hospital & Institute | 2024-06-01 |
| Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial (NCT06588998) | Amr Anwar Mohamed Ellithy Yousef | 2024-06-01 |
| A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C (NCT05975021) | Windtree Therapeutics | 2024-06-01 |
| Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke (NCT05892510) | University of Melbourne | 2024-06-01 |
| SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer (NCT06422156) | Peking University Third Hospital | 2024-06-01 |
| Effect of Intrathecal Magnesium Sulfate Versus Intravenous Magnesium Sulfate on Postoperative Pain After Abdominal Hysterectomy (NCT06367595) | Assiut University | 2024-06-01 |
| Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) (NCT06963060) | Wei Gong | 2024-06-01 |
| Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement (NCT06403046) | Beni-Suef University | 2024-06-01 |
| Safety and Efficacy of Treg Cell in the Treatment of GVHD (NCT06411184) | Xuzhou Medical University | 2024-06-01 |
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage (NCT05627752) | Zhongnan Hospital | 2024-06-01 |
| Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients (NCT06945679) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2024-06-01 |
| Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. (NCT06393361) | Chinese PLA General Hospital | 2024-06-01 |
| A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) (NCT04935762) | CuraSen Therapeutics, Inc. | 2024-06-01 |
| An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency (NCT07644832) | Shanghai RAAS Blood Products Co., Ltd. | 2024-05-31 |
| Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy (NCT06283550) | Innovaderm Research Inc. | 2024-05-31 |
| Avelumab, Palbociclib and Axitinib in Advanced RCC (NCT05176288) | Bradley A. McGregor, MD | 2024-05-31 |
| Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy (NCT06377696) | Mayo Clinic | 2024-05-31 |
| Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation (NCT06218420) | Assistance Publique - Hôpitaux de Paris | 2024-05-31 |
| BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) (NCT05922761) | Dana-Farber Cancer Institute | 2024-05-31 |
| Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC (NCT06361758) | Shanghai Zhongshan Hospital | 2024-05-31 |
| Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma (NCT05922501) | Massachusetts General Hospital | 2024-05-31 |
| The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM (NCT06427252) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-31 |
| TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer (NCT06415318) | Sun Yat-sen University | 2024-05-31 |
| Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System (NCT06142461) | PharmaJet, Inc. | 2024-05-31 |
| Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care (NCT06556550) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2024-05-31 |
| Metreleptin in Anorexia Nervosa (NCT06305182) | Gabriella Milos | 2024-05-31 |
| A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss (NCT05593497) | VA Office of Research and Development | 2024-05-31 |
| Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies (NCT04406948) | MGC Pharmaceuticals d.o.o | 2024-05-30 |
| R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT06594640) | Institute of Hematology & Blood Diseases Hospital, China | 2024-05-30 |
| Peripheral Nerve Injections for CRPS (NCT04744675) | Ottawa Hospital Research Institute | 2024-05-30 |
| Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis (NCT06106672) | COUR Pharmaceutical Development Company, Inc. | 2024-05-30 |
| A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia (NCT05963074) | Janssen Research & Development, LLC | 2024-05-30 |
| A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (NCT06401044) | Amgen | 2024-05-30 |
| Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia (NCT06946940) | Rambam Health Care Campus | 2024-05-30 |
| Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial) (NCT06436612) | Jonsson Comprehensive Cancer Center | 2024-05-30 |
| NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer (NCT05837455) | Washington University School of Medicine | 2024-05-30 |
| A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women (NCT06393673) | Hansoh BioMedical R&D Company | 2024-05-30 |
| The Role of SGLT2i in Management of Moderate AS (NCT06469645) | University of East Anglia | 2024-05-30 |
| Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study (NCT06111768) | Yale University | 2024-05-30 |